Analogue-Based Drug Discovery III

János Fischer, C. Robin Ganellin, David Rotella

Research output: Book/ReportBookResearchpeer-review

8 Citations (Scopus)

Abstract

Most drugs are analogue drugs. There are no general rules how a new drug can be discovered, nevertheless, there are some observations which help to find a new drug, and also an individual story of a drug discovery can initiate and help new discoveries. Volume III is a continuation of the successful book series with new examples of established and recently introduced drugs. The major part of the book is written by key inventors either as a case study or a study of an analogue class. With its wide range across a variety of therapeutic fields and chemical classes, this is of interest to virtually every researcher in drug discovery and pharmaceutical chemistry, and -- together with the previous volumes -- constitutes the first systematic approach to drug analogue development.

Original languageEnglish
PublisherWiley-VCH
ISBN (Print)9783527330737
DOIs
StatePublished - 18 Dec 2012

Fingerprint

Drug Discovery
Pharmaceutical Preparations
Inventors
Pharmaceutical Chemistry
Research Personnel

Cite this

Fischer, János ; Ganellin, C. Robin ; Rotella, David. / Analogue-Based Drug Discovery III. Wiley-VCH, 2012.
@book{438e4dc71b4a4709883fdd4e803b10ec,
title = "Analogue-Based Drug Discovery III",
abstract = "Most drugs are analogue drugs. There are no general rules how a new drug can be discovered, nevertheless, there are some observations which help to find a new drug, and also an individual story of a drug discovery can initiate and help new discoveries. Volume III is a continuation of the successful book series with new examples of established and recently introduced drugs. The major part of the book is written by key inventors either as a case study or a study of an analogue class. With its wide range across a variety of therapeutic fields and chemical classes, this is of interest to virtually every researcher in drug discovery and pharmaceutical chemistry, and -- together with the previous volumes -- constitutes the first systematic approach to drug analogue development.",
author = "J{\'a}nos Fischer and Ganellin, {C. Robin} and David Rotella",
year = "2012",
month = "12",
day = "18",
doi = "10.1002/9783527651085",
language = "English",
isbn = "9783527330737",
publisher = "Wiley-VCH",

}

Analogue-Based Drug Discovery III. / Fischer, János; Ganellin, C. Robin; Rotella, David.

Wiley-VCH, 2012.

Research output: Book/ReportBookResearchpeer-review

TY - BOOK

T1 - Analogue-Based Drug Discovery III

AU - Fischer, János

AU - Ganellin, C. Robin

AU - Rotella, David

PY - 2012/12/18

Y1 - 2012/12/18

N2 - Most drugs are analogue drugs. There are no general rules how a new drug can be discovered, nevertheless, there are some observations which help to find a new drug, and also an individual story of a drug discovery can initiate and help new discoveries. Volume III is a continuation of the successful book series with new examples of established and recently introduced drugs. The major part of the book is written by key inventors either as a case study or a study of an analogue class. With its wide range across a variety of therapeutic fields and chemical classes, this is of interest to virtually every researcher in drug discovery and pharmaceutical chemistry, and -- together with the previous volumes -- constitutes the first systematic approach to drug analogue development.

AB - Most drugs are analogue drugs. There are no general rules how a new drug can be discovered, nevertheless, there are some observations which help to find a new drug, and also an individual story of a drug discovery can initiate and help new discoveries. Volume III is a continuation of the successful book series with new examples of established and recently introduced drugs. The major part of the book is written by key inventors either as a case study or a study of an analogue class. With its wide range across a variety of therapeutic fields and chemical classes, this is of interest to virtually every researcher in drug discovery and pharmaceutical chemistry, and -- together with the previous volumes -- constitutes the first systematic approach to drug analogue development.

UR - http://www.scopus.com/inward/record.url?scp=84891582279&partnerID=8YFLogxK

U2 - 10.1002/9783527651085

DO - 10.1002/9783527651085

M3 - Book

SN - 9783527330737

BT - Analogue-Based Drug Discovery III

PB - Wiley-VCH

ER -